Skip to Main Content
Menu Button
About
Team
Partners and Collaborators
Investors
Science
Our Approach
Tertiary Lymphoid Structures
Publications
Pipeline
Life at Mestag
Our Culture
Team Mestag
Opportunities
News & Events
Press Releases
Events & Presentations
Contact
Lines
M300 Publications
Conditionally active, therapeutic lymphotoxin beta receptor (LTBR) agonist bispecific antibodies for induction of tertiary lymphoid structures in the treatment of solid tumors
April 29, 2024
Read More